Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer

Clinical trial NCT02125617 · TERMINATED

Trial details

NCT number: NCT02125617
Sponsor: Kristoffer Rohrberg
Status: TERMINATED
Study type: OBSERVATIONAL

Prostatic Neoplasms

Start date: 2014-01-01
Primary completion: 2016-07-15
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.